Annual secretarial compliance report March 31, 2025
FERMENTA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Fermenta Biotech has submitted its Annual Secretarial Compliance Report for FY 2024-25, as required under SEBI's Listing Regulations. The report, issued by V.N. Deodhar & Co., Company Secretaries, confirms that the company examined all relevant SEBI regulations covering listing obligations, insider trading, takeover code, and other areas. The practicing company secretary reported NIL deviations and NIL actions taken by SEBI or stock exchanges against the company during the review period. All 13 compliance parameters checked — including secretarial standards, board policies, website disclosures, director eligibility, related party transactions, and insider trading norms — were marked as compliant. No statutory auditor resigned during the year and no material subsidiaries exist.
This is a routine yearly compliance filing with no red flags — no penalties, warnings, or regulatory actions were reported. For shareholders, it signals that Fermenta Biotech is in good regulatory standing with clean corporate governance for FY 2024-25, though the filing itself is unlikely to move the stock price.